Tumor growth and progression is driven by cancer stem cells that possess self-renewal ability [39], and the maintenance of CSCs is regulated by key embryonic stem cell transcription factors (i.e. SOX2, OCT4 and NANOG) [40–42]. This evidence concerns the gene SOX2 and cancer.